Atai Life Sciences N.V. (NQ: ATAI )
5.140 USD -0.120 (-2.28%) Streaming Delayed Price Updated: 4:00 PM EST, Jan 24, 2022 Add to My Watchlist
Stories about Atai Life Sciences N.V.
Psychedelic Stock Gainers And Losers From January 24, 2022
January 24, 2022
GAINERS: Field Trip Health (NASDAQ:FTRP) shares closed up 6.45% at $1.98 Allied (OTC:ALID) shares closed up 2.27% at $1.80 Seelos ...
Weekend Update: Only 2 Psychedelic Drug Stocks Are Up YTD
January 23, 2022
This article updates the performances of the 16 largest capitalized clinical-stage psychedelic and marijuana drug companies researching the treatment of a wide variety of mental illnesses out of a...
Psychedelic Stock Gainers And Losers From January 21, 2022
January 21, 2022
GAINERS: GH Research (NASDAQ:GHRS) shares closed up 1.18% at $17.19 LOSERS: Mindset Pharma (OTC:MSSTF) shares closed down ...
Psychedelic Stock Gainers And Losers From January 20, 2022
January 20, 2022
GAINERS: Small Pharma (OTC:DMTTF) shares closed up 14.55% at $0.21 GH Research (NASDAQ:GHRS) shares closed up 3.35% at $16.99 Field ...
GAINERS: Revive Therapeutics (OTC:RVVTF) shares closed up 14.94% at $0.25 ATAI Life Sciences (NASDAQ:ATAI) shares closed up 3.53% at ...
Psychedelic Stock Gainers And Losers From January 18, 2022
January 18, 2022
GAINERS: Cybin (AMEX:CYBN) shares closed up 1.90% at $1.07 Intelgenx Technologies (OTC:IGXT) shares closed up 1.41% at ...
Psyched: Delix Raises $30M, New Ketamine Study For Alcohol Use Disorder, FDA Approves Ketamine Trial For ALS
January 18, 2022
New Awakn Study Shows Ketamine Has Potential To Treat Alcoholism Awakn Life Sciences Corp. (NEO: AWKN) (OTCQB: AWKNF) published ...
Psychedelic Stock Gainers And Losers From January 17, 2022
January 17, 2022
GAINERS: Allied (OTC:ALID) shares closed up 16.57% at $2.11 Filament Health (OTC:FLHLF) shares closed up 11.49% at $0.30 GH Research ...
The Daily Biotech Pulse: Biogen Slumps As CMS Announces Restrictive Coverage For Aduhelm, Aclaris CMO Departs, Immuron Spikes On US Military Award
January 12, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Biogen Shares Slip On ...
Why Jim Cramer Likes Illumina And Enterprise Products Partners
January 06, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Illumina, Inc. (NASDAQ: ILMN) has got "unbelievable ...
Year-End Summary: Marijuana & Psychedelic Compounds-Based Drug Stocks Index Went DOWN -33.6% In 2021!
January 02, 2022
Which index performed the best in 2021, the Marijuana Drug Stocks Index, or the Psychedelic Compounds-Based Drug Stocks Index? Which constituents contributed to their performances? This article has the...
Tags Market News
2021 Was The Year Psychedelics Conquered Capitalism...Or Is It The Other Way Around?
December 30, 2021
Witnessing an entirely new industry being created from scratch is a rare and historic event, one that brings with it tremendous ...
Analysts Anticipate KOMP Will Reach $80
December 27, 2021
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
From ETF Channel
Steep Decline In Cannabis & Psychedelic Compounds-Based Drug Stocks Continues: DOWN -16.6% MTD
December 24, 2021
All 12 constituents in the Marijuana & Psychedelic Compounds-Based Drug Stocks Index continue to decline. How do their performances compare month-to-date and YTD?
The Year In Review For Psychedelic Drug Stocks: 2021
December 21, 2021
2021 was two different "years" for the psychedelic drug industry. Impressive progress in drug R&D and clinics; stocks pushed down to absurdly lean multiples.
Mobile Clinics Featuring Novel Mental Health Treatments Reportedly Coming to Florida and Nevada
December 20, 2021
Photo by Insung Yoon on Unsplash The following post was written and/or published as a collaboration between Benzinga’s in-house ...
46 Biggest Movers From Yesterday
December 16, 2021
Gainers Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) gained 34.1% to settle at $12.58 on Wednesday. CMC Materials, Inc. ...
36 Stocks Moving In Wednesday's Mid-Day Session
December 15, 2021
Gainers Nxt-ID, Inc. (NASDAQ: NXTD) shares gained 28.9% to $3.21 after the company said it was awarded U.S. General Services ...
Dow Down Triple Digits as Fed Meeting Wraps Up
December 15, 2021
Stocks have deepened their morning losses by midday, with the Dow Jones Industrial Average down 119 points, while both the Nasdaq Composite and S&P 500 Index are firmly in the red as well.
Following the market opening Wednesday, the Dow traded down 0.26% to 35,453.17 while the NASDAQ fell 0.62% to 15,142.70. The S&P ...
Entheon Biomedical Reports Launching Multiple Studies to Advance Psychedelic-Based Mental Health Treatments
December 13, 2021
Image provided by Flickr The following post was written and/or published as a collaboration between Benzinga’s in-house ...
Trip to Sustainability? This Company Is Developing Synthetic Psychedelics To Attempt to Fight Mental Illness
December 13, 2021
Photo by Raimond Klavins on Unsplash The following post was written and/or published as a collaboration between Benzinga’s ...
Cannabis & Psychedelic Compound-Based Drug Stocks Continue To Decline
December 12, 2021
The six marijuana-based clinical-stage stocks are down 31.1% since the end of June; the 9 psychedelic compound-based clinical-stage stocks with market caps under $1B are down 36.3% in that same...
Psilera's DMT-Derived Drug Sees Positive Results in Pre-Clinical Study
December 09, 2021
Psilerais a Florida-based biotechnology company focused on developing drugs to treat mental disorders using non-hallucinogenic ...
National Institute on Drug Abuse Will Test Ibogaine For Addiction Treatment As Drug Deaths Crest 100,000
December 08, 2021
The U.S. government has taken a significant step toward tackling the mounting national substance addiction crisis bypartnering ...
This Company Is Making Synthetic Psychedelics With a Goal To Combat Mental Illness
December 08, 2021
Photo by Michael Longmire on Unsplash The following post was written and/or published as a collaboration between Benzinga’s ...
New York's Horizons Psychedelic Conference Highlights Big Donations In The Growing Industry
December 07, 2021
Venture capitalistand businessmanStephen Jurvetsonis joiningan expanding group of prominent investors who are ...
Both Marijuana & Psychedelic Compounds-Based Drug Stocks Indexes Declined Sharply In November
December 01, 2021
A look at which critical stage drug stock category performed best in November and which constituents contributed to that performance.
Analyst Ratings For ATAI Life Sciences
November 30, 2021
Over the past 3 months, 6 analysts have published their opinion on ATAI Life Sciences (NASDAQ:ATAI) stock. These analysts are typically ...